Skip to Content

← See all Childrens Allegra Allergy brands

Childrens Allegra Allergy by Chattem, Inc.

Dosage form: tablet, orally disintegrating
Ingredients: FEXOFENADINE HYDROCHLORIDE 30mg
Labeler: Chattem, Inc.
NDC Code: 41167-4232

Childrens Allegra Allergy

Drug Facts

Active ingredient

(in each tablet)

Fexofenadine HCI 30 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, water eyes
  • itching of the nose or throat

Warnings

Do not use

if you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have

kidney disease. Your doctor should determine if you need a different dose.

When using this product

  • do not take more than directed
  • do not take at the same time as aluminum or magnesium antacids
  • do not take with fruit juices (see Directions)

Stop use and ask a doctor if

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions
  • place 1 tablet on tongue; tablet disintegrates, with or without water
adults and children 12 years of age and overtake 2 tablets every 12 hours on an empty stomach; do not take more than 4 tablets in 24 hours
children 6 to under 12 years of agetake 1 tablet every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hours
children under 6 years of agedo not use
adults 65 years of age and olderask a doctor
consumers with kidney diseaseask a doctor

Other information
  • phenylketonurics: contains phenylalanine 3.8 mg per tablet
  • safety sealed: do not use if carton is opened or if individual blister units are torn or opened
  • store between 20º and 25ºC (68º and 77ºF)
  • use tablet immediately after opening individual blister
  • contains lactose

Inactive ingredients

aspartame, crospovidone, flavors, lactose monohydrate, magnesium stearate, methacrylic acid copolymer, microcrystalline cellulose, povidone, silicon dioxide

Questions or comments?

call toll-free 1-800-633-1610 or www.allegra.com 

Dist. By: Chattem, Inc, a Sanofi Company,

Chattanooga, TN 37409-0219 ©2015             0100036-01

PRINCIPAL DISPLAY PANEL

NDC 41167-4232-1
NON-DROWSY

Children’s

Allegra
® 
Allergy

fexofenadine HC
l orally disintegrating
tablet 30
mg/antihistamine
Indoor and Outdoor Aller
gies
Orange Cream flavor

12 Orally Disintegrating Tablets

PRINCIPAL DISPLAY PANEL

NDC 41167-4232-6
NON-DROWSY

Children’s

Allegra
® 
Allergy

fexofenadine
HCl orally disintegrating
tablet 30
mg/antihistamine
Indoor and Outdoor Aller
gies
Orange Cream flavor

24 Orally Disintegrating Tablets

CHILDRENS ALLEGRA ALLERGY 
fexofenadine hydrochloride tablet, orally disintegrating
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-4232
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
FEXOFENADINE HYDROCHLORIDE (FEXOFENADINE) FEXOFENADINE HYDROCHLORIDE30 mg
Inactive Ingredients
Ingredient NameStrength
ASPARTAME 
CROSPOVIDONE 
MAGNESIUM STEARATE 
LACTOSE MONOHYDRATE 
CELLULOSE, MICROCRYSTALLINE 
POVIDONE 
SILICON DIOXIDE 
Product Characteristics
ColorWHITEScoreno score
ShapeROUNDSize11mm
FlavorORANGE (Orange Cream) Imprint Codee;311;AV
Contains    
Packaging
#Item CodePackage Description
1NDC:41167-4232-12 BLISTER PACK in 1 CARTON
16 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
2NDC:41167-4232-64 BLISTER PACK in 1 CARTON
26 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02190901/02/2014
Labeler - Chattem, Inc. (003336013)

 
Chattem, Inc.

← See all Childrens Allegra Allergy brands

Medically reviewed on Aug 20, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide